BP133

多库酯 钠盐

British Pharmacopoeia (BP) Reference Standard

• 别名: AOT, 二辛基琥珀酸磺酸钠 钠盐, 双(2-乙基己基)磺基琥珀酸钠, 双(2-乙己基)磺基丁二酸钠 钠盐, 磺基丁二酸钠二辛酯 钠盐, 磺基琥珀酸二乙基己酯钠 钠盐
• 经验公式（希尔记法）: C₂₀H₃₇NaO₇S
• CAS号: 577-11-7
• 分子量: 444.56
• Beilstein: 4117588
• EC號碼: 209-406-4
• MDL號碼: MFCD00012455
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: docusate calcium
• 形狀: waxy solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 形式: neat
• SMILES 字串: [Na+].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S([O-])(=O)=O
• InChI: 1S/C20H38O7S.Na/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2;/h16-18H,5-15H2,1-4H3,(H,23,24,25);/q;+1/p-1
• InChI 密鑰: APSBXTVYXVQYAB-UHFFFAOYSA-M

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Docusate sodium BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Co-danthrusate Capsules

Docusate Capsules

Compound Docusate Enema

Docusate Oral Solution

在烃类溶剂中形成反相胶束；适合于溶解主要的髓鞘跨膜蛋白脂质

包裝

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS05
• 訊號詞: Danger
• 危險聲明: H315,H318
• 防範說明: P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P362 + P364
• 危險分類: Eye Dam. 1 - Skin Irrit. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2